SPIDIMAN
Single-Port Insulin Infusion for Improved Diabetes Management
| Coordinatore | JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH
Organization address
address: LEONHARDSTRASSE 59 contact info |
| Nazionalità Coordinatore | Austria [AT] |
| Sito del progetto | http://www.joanneum.at/en/health/btm/projects/spidiman.html |
| Totale costo | 6˙378˙173 € |
| EC contributo | 4˙941˙738 € |
| Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
| Code Call | FP7-HEALTH-2012-INNOVATION-1 |
| Funding Scheme | CP-FP |
| Anno di inizio | 2012 |
| Periodo (anno-mese-giorno) | 2012-11-01 - 2016-10-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH
Organization address
address: LEONHARDSTRASSE 59 contact info |
AT (GRAZ) | coordinator | 1˙172˙084.40 |
| 2 |
RESCOLL
Organization address
address: ALLEE GEOFFROY SAINT HILAIRE 8 contact info |
FR (PESSAC) | participant | 794˙996.40 |
| 3 |
Medizinische Universitaet Graz
Organization address
address: AUENBRUGGERPLATZ 2 contact info |
AT (GRAZ) | participant | 652˙436.10 |
| 4 |
Profil Institut fur Stoffwechselforschung GmbH
Organization address
address: Hellersbergstrasse 9 contact info |
DE (Neuss) | participant | 627˙377.20 |
| 5 |
CENTRE HOSPITALIER DE LUXEMBOURG
Organization address
address: RUE BARBLE 4 contact info |
LU (LUXEMBOURG) | participant | 490˙096.25 |
| 6 |
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
Organization address
address: The Old Schools, Trinity Lane contact info |
UK (CAMBRIDGE) | participant | 395˙598.40 |
| 7 |
PYRO SCIENCE GMBH
Organization address
address: HUBERTUSSTRASSE 35 contact info |
DE (AACHEN) | participant | 336˙800.00 |
| 8 |
AKIRA TECHNOLOGIES SARL
Organization address
address: RUE DE LA GALUPE ZA SAINT 17 contact info |
FR (BAYONNE) | participant | 334˙650.00 |
| 9 |
BIONANONET FORSCHUNGSGESELLSCHAFT MBH
Organization address
address: ELISABETHSTRASSE 9-11 contact info |
AT (GRAZ) | participant | 137˙700.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
Existing therapeutic devices for diabetic patients suffer from bulky size, inaccurate measurements and the difficulties of handling two body interfaces. Suboptimal control of blood glucose levels in type 1 or type 2 diabetes mellitus patients results in periods of hypo- and hyperglycaemia leading to severe and life-threatening complications. Exploiting a novel glucose sensor technology, SPIDIMAN aims to improve glycaemic management for better quality of life and healthier aging. The consortium will develop a new coating technology to apply a glucose-sensitive fluorescent dye onto a standard insulin catheter and incorporate this integrated glucose sensor into a single-port artificial pancreas system. Advanced optical continuous glucose monitoring technology (smart tattoos) with improved sensor accuracy, faster response times, wider dynamic range and higher signal stability will advance diabetes management by reducing hypo- and hyperglycaemic episodes. Within SPIDIMAN, research-intensive European SMEs will develop an innovative artificial pancreas approach, and experienced participants will perform clinical validation in a European network of specialised diabetes centres. SPIDIMAN will thus pave the way for a single-port device that integrates improved glucose measurement and more accurate insulin delivery to provide better glycaemic management in patients with insulin-dependent diabetes. The new device is expected to be particularly suitable for patients in childhood and adolescence, who will form a special focus of the project.
Introduzione (Teaser)
Blood insulin levels trigger storage or release of glucose, a simple sugar necessary for all cellular functions but that can cause great damage in excess. Enhanced glucose monitoring during insulin therapy will improve quality of life for diabetics.